Teladoc Health (TDOC) Change in Receivables (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Change in Receivables data on file, last reported at $21.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 37.5% year-over-year to $21.0 million; the trailing twelve-month figure through Mar 2026 stood at -$19.4 million (down 209.12% YoY), and the FY2025 full-year result was -$25.1 million, down 6800.27% from the prior year.
• Change in Receivables advanced to $21.0 million in Q1 2026, from -$17.5 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $27.8 million in Q1 2022 to a low of -$17.5 million in Q4 2025.
• A 5-year average of $3.3 million and a median of $3.8 million in 2022 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables plunged 580.36% in 2023 and soared 815.89% in 2025, its largest moves.
• Tracing TDOC's Change in Receivables over 5 years: stood at $3.8 million in 2022, then surged by 152.07% to $9.6 million in 2023, then plunged by 57.62% to $4.0 million in 2024, then plunged by 531.16% to -$17.5 million in 2025, then surged by 220.24% to $21.0 million in 2026.
• Business Quant data shows TDOC's Change in Receivables at $21.0 million in Q1 2026, -$17.5 million in Q4 2025, and -$16.2 million in Q3 2025.